Literature DB >> 941097

Catabolism of secretin by the liver and kidney.

P J Curtis, H R Fender, P L Rayford, J C Thompson.   

Abstract

We have investigated the roles of the liver and the kidney in the catabolism of secretin, using a specific and sensitive radioimmunoassay. Dogs were prepared with sampling catheters in the aorta, hepatic vein, portal vein, and renal vein and with electromagnetic flow probes on the portal vein, hepatic artery, and renal artery. Secretin levels in the vessels entering and leaving the liver and kidney were determined by radioimmunoassay and the total mass of secretin [concentration (picograms per milliliter) X plasma flow rate (milliliter per minute)] was calculated during an intravenous infusion of exogenous secretin and during release of endogenous secretin by acidification of the proximal intestine. The total masses of secretin entering and leaving the liver were the same during secretin infusion and during the release of endogenous secretin. Under conditions of elevation of plasma secretin, however, the kidney extracted 30 percent of arterial secretin during secretin infusion and 45 percent during release of endogenous secretin. Clearly the kidney is a major site of secretin catabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941097

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Absence of hepatic extraction of gastric inhibitory polypeptide in conscious dogs.

Authors:  Z Chap; T M O'Dorisio; S Cataland; J B Field
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

2.  Effect of renal failure on gastrointestinal hormones.

Authors:  J Hansky
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

3.  Catabolism of gastrin and secretin.

Authors:  J C Thompson; O L Llanos; R K Teichmann; A Schafmayer; P L Rayford
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

4.  Stimulation by secretin of bilirubin UDP-glycosyltransferase activities and of cytochrome P-450 concentration in rat liver.

Authors:  G L Ricci; J Fevery
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

5.  Effect of renal failure or portacaval shunt on release of neurotensin in man.

Authors:  E R Eaves; J Hansky
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

6.  Alterations of exocrine pancreas in end-stage renal disease. Do they reflect a clinically relevant uremic pancreopathy?

Authors:  M Ventrucci; C Campieri; M Di Stefano; G M Ubalducci; S Li Bassi; A Di Grazia; A Giudicissi; D Festi
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

Review 7.  Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?

Authors:  Sanna Laurila; Eleni Rebelos; Miikka-Juhani Honka; Pirjo Nuutila
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-04       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.